Mark Tangney

5.1k citations

111 papers · 4.2k · 2 hit papers · h-index 35

Impact in

Biotechnology top 0.2%
- Cancer Research and Treatments
- Microbial Inactivation Methods
Oncology top 5%

Papers in

Biotechnology 48
- Cancer Research and Treatments 37
- Microbial Inactivation Methods 8
Genetics 36
- Virus-based gene therapy research 34

Co-authors: Gerald C. O’Sullivan (36 shared papers)Gregor Reid (3 shared papers)Camilla Urbaniak (3 shared papers)Joanne Cummins (4 shared papers)M. Brackstone (2 shared papers)Leslie Scott (2 shared papers)Gregory Brian Gloor (2 shared papers)Michelle A. Cronin (12 shared papers)
Journals: Current Gene Therapy (6 papers)Journal of Controlled Release (6 papers)Applied and Environmental Microbiology (5 papers)Scientific Reports (4 papers)Journal of Visualized Experiments (4 papers)
Partner nations: Ireland United Kingdom United States

In The Last Decade

Mark Tangney

109 papers receiving 4.1k citations

Mark Tangney's Hit Papers

align trajectories log scale

The Microbiota of Breast Tissue and Its Association with Breast Cancer 2016 · 501 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2016 Applied and Environmental Microbiology
2014 Applied and Environmental Microbiology

Peers

Countries citing papers authored by Mark Tangney

Since Specialization

Citations

This map shows the geographic impact of Mark Tangney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Tangney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Tangney more than expected).

Fields of papers citing papers by Mark Tangney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Tangney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Tangney. The network helps show where Mark Tangney may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Tangney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Tangney Line = papers co-authored together Mark Tangney links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 111 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The Microbiota of Breast Tissue and Its Association with Breast Cancer Applied and Environmental Microbiology ·Camilla Urbaniak, Gregory Brian Gloor, M. Brackstone, Leslie Scott, Mark Tangney, Gregor Reid Hit paper breakdown →	2016	501
2	Microbiota of Human Breast Tissue Applied and Environmental Microbiology ·Camilla Urbaniak, Joanne Cummins, M. Brackstone, Jean M. Macklaim, Gregory Brian Gloor, Chwanrow Karim Baban, Leslie Scott, Deidre M. O'Hanlon, Jeremy P. Burton, Kevin P. Francis, Mark Tangney, Gregor Reid Hit paper breakdown →	2014	425
3	Local bacteria affect the efficacy of chemotherapeutic drugs Scientific Reports ·Panos Lehouritis, Joanne Cummins, Michael Stanton, C. Murphy, Florence O. McCarthy, Gregor Reid, Camilla Urbaniak, William L. Byrne, Mark Tangney	2015	252
4	Bacteria as vectors for gene therapy of cancer PubMed ·Chwanrow Karim Baban, Michelle A. Cronin, Deirdre M O'Hanlon, Gerald C. O’Sullivan, Mark Tangney	2010	148
5	Bacteria and tumours: causative agents or opportunistic inhabitants? Infectious Agents and Cancer ·Joanne Cummins, Mark Tangney	2013	139
6	Electrochemotherapy Annals of Surgery ·John O. Larkin, Chris G. Collins, Simon J. Aarons, Mark Tangney, Maria C. Whelan, Seamus O Reily, Oscar S. Breathnach, Declan M. Soden, Gerald C. O Sullivan	2007	138
7	High Resolution In Vivo Bioluminescent Imaging for the Study of Bacterial Tumour Targeting PLoS ONE ·Michelle A. Cronin, Ali R. Akin, Sara Collins, Jeff Meganck, Jae-Beom Kim, Chwanrow Karim Baban, Susan A. Joyce, Gooitzen M. van Dam, Ning Zhang, Douwe van Sinderen, Gerald C. O’Sullivan, Noriyuki Kasahara, Cormac G. M. Gahan, Kevin P. Francis, Mark Tangney	2012	116
8	Isolation and characterization of anti-Salmonella lactic acid bacteria from the porcine gastrointestinal tract Letters in Applied Microbiology ·P Casey, G. Casey, Gillian E. Gardiner, Mark Tangney, Catherine Stanton, R. Paul Ross, Colin Hill, Gerald F. Fitzgerald	2004	112
9	Orally Administered Bifidobacteria as Vehicles for Delivery of Agents to Systemic Tumors Molecular Therapy ·Michelle A. Cronin, (unknown), Simon Rajendran, Shereen M. El Mashad, Douwe van Sinderen, Gerald C. O’Sullivan, Mark Tangney	2010	100
10	Evaluation of Cellular Uptake and Gene Transfer Efficiency of Pegylated Poly- l -lysine Compacted DNA: Implications for Cancer Gene Therapy Molecular Pharmaceutics ·Melanie Walsh, Mark Tangney, Martin J. O’Neill, John O. Larkin, Declan M. Soden, Sharon L. McKenna, R. Darcy, Gerald C. O’Sullivan, Caitríona M. O’Driscoll	2006	93
11	Improved Luciferase Tagging System for Listeria monocytogenes Allows Real-Time Monitoring In Vivo and In Vitro Applied and Environmental Microbiology ·Christian U. Riedel, Ian R. Monk, Pat G. Casey, (unknown), Gerald C. O’Sullivan, Mark Tangney, Colin Hill, Cormac G. M. Gahan	2007	91
12	Synthetic Biology in the Driving Seat of the Bioeconomy Trends in biotechnology ·Yensi Flores Bueso, Mark Tangney	2017	85
13	Tumour Targeting with Systemically Administered Bacteria Current Gene Therapy ·(unknown), Gerald C. O’Sullivan, Mark Tangney	2010	78
14	Successful application of targeted electrochemotherapy using novel flexible electrodes and low dose bleomycin to solid tumours Cancer Letters ·Declan M. Soden, John O. Larkin, Chris G. Collins, Mark Tangney, Simon J. Aarons, J. Piggott, Anthony Morrissey, Colum P. Dunne, Gerald C. O’Sullivan	2005	77
15	Sequence-Based Characterization of Intratumoral Bacteria—A Guide to Best Practice Frontiers in Oncology ·Sidney Peter Walker, Mark Tangney, Marcus Joakim Claesson	2020	71
16	A Novel Listeria monocytogenes -Based DNA Delivery System for Cancer Gene Therapy Human Gene Therapy ·Jan Peter van Pijkeren, (unknown), Ian R. Monk, Michelle A. Cronin, Simon Rajendran, Gerald C. O’Sullivan, Cormac G. M. Gahan, Mark Tangney	2010	70
17	Bacterial-directed enzyme prodrug therapy Journal of Controlled Release ·Panos Lehouritis, Caroline J. Springer, Mark Tangney	2013	62
18	Intratumoural production of TNFα by bacteria mediates cancer therapy PLoS ONE ·C. Murphy, Elizabeth A. Rettedal, Panos Lehouritis, Ciarán Devoy, Mark Tangney	2017	54
19	Viral Vectors in Cancer Immunotherapy: Which Vector for Which Strategy? Current Gene Therapy ·Sara Collins, Barbara‐ann Guinn, Patrick T. Harrison, Martina F. Scallan, Gerald C. O’Sullivan, Mark Tangney	2008	53
20	Polymer coatings for delivery of nucleic acid therapeutics Journal of Controlled Release ·Richard Laga, Robert C. Carlisle, Mark Tangney, Karel Ulbrich, (unknown)	2012	51

About Mark Tangney

Mark Tangney is a scholar working on Biotechnology, Genetics, Molecular Biology, Oncology and Immunology, having authored 111 papers that have together received 4.2k indexed citations. Recurring topics across this work include Cancer Research and Treatments (37 papers), Virus-based gene therapy research (34 papers), Gut microbiota and health (13 papers), Bacteriophages and microbial interactions (11 papers), Microbial Inactivation Methods (8 papers), Immunotherapy and Immune Responses (8 papers), CAR-T cell therapy research (7 papers) and bioluminescence and chemiluminescence research (7 papers). The work is most often cited by research in Biotechnology (1.4k citations), Oncology (819 citations), Molecular Biology (2.1k citations), Genetics (692 citations) and Biomedical Engineering (852 citations). Mark Tangney has collaborated with scholars based in Ireland, United Kingdom and United States. Frequent co-authors include Gerald C. O’Sullivan, Gregor Reid, Camilla Urbaniak, Joanne Cummins, M. Brackstone, Leslie Scott, Gregory Brian Gloor, Michelle A. Cronin, Panos Lehouritis and Yensi Flores Bueso. Their work appears in journals such as Current Gene Therapy, Journal of Controlled Release, Applied and Environmental Microbiology, Scientific Reports and Journal of Visualized Experiments.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Mark Tangney

Impact in

Papers in i

In The Last Decade

Mark Tangney

Mark Tangney's Hit Papers

Peers

Countries citing papers authored by Mark Tangney

Fields of papers citing papers by Mark Tangney

All Works

About Mark Tangney

Explore authors with similar magnitude of impact

Papers in